- Home
- PHIO
as of 12-12-2025 3:41pm EST
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | KING OF PRUSSIA |
| Market Cap: | 12.3M | IPO Year: | N/A |
| Target Price: | $10.67 | AVG Volume (30 days): | 411.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.97 - $9.79 | Next Earning Date: | 11-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered PHIO Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Phio Pharmaceuticals Corp. (PHIO)
Chairman, Pres. & CEO
Avg Cost/Share
$1.14
Shares
5,000
Total Value
$5,700.00
Owned After
281,421
SEC Form 4
Chairman, Pres. & CEO
Avg Cost/Share
$1.27
Shares
5,000
Total Value
$6,350.00
Owned After
281,421
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Bitterman Robert J | PHIO | Chairman, Pres. & CEO | Nov 21, 2025 | Buy | $1.14 | 5,000 | $5,700.00 | 281,421 | |
| Bitterman Robert J | PHIO | Chairman, Pres. & CEO | Nov 18, 2025 | Buy | $1.27 | 5,000 | $6,350.00 | 281,421 |
Compare PHIO vs Leading Stocks
See how PHIO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PHIO Phio Pharmaceuticals Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.